HTG Molecular Diagnostics, Inc.
HTGM · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,055 | -$4,693 | -$4,516 | -$5,888 |
| Dep. & Amort. | $86 | $100 | $134 | $168 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $137 | $141 | $175 | $231 |
| Change in WC | -$179 | $1,189 | -$500 | -$668 |
| Other Non-Cash | $647 | $1,239 | $112 | $307 |
| Operating Cash Flow | -$4,364 | -$2,023 | -$4,595 | -$5,850 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | $0 | -$8 | -$7 |
| Net Acquisitions | $0 | -$99,828,506 | $0 | $0 |
| Inv. Purchases | -$3,538 | $0 | $0 | -$7,611 |
| Inv. Sales/Matur. | -$27 | $3,300 | $5,050 | $6,200 |
| Other Inv. Act. | $27 | $99,828,506 | $100 | $4 |
| Investing Cash Flow | -$3,545 | $3,300 | $5,142 | -$1,413 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $1,402 | $0 | $1,402 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,310 | $7,700 | -$3,078 | -$1,584 |
| Financing Cash Flow | -$1,310 | $7,700 | -$3,078 | -$1,584 |
| Forex Effect | $4 | $21 | -$13 | -$11 |
| Net Chg. in Cash | -$9,214 | $8,998 | -$2,544 | -$8,858 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,211 | $3,212 | $5,757 | $14,614 |
| End Cash | $2,996 | $12,211 | $3,212 | $5,757 |
| Free Cash Flow | -$4,370 | -$2,023 | -$4,603 | -$5,856 |